Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02103348 · ClinicalTrials.gov registry record
Characterizing Asthma Sputum Elasticity in the UCSF Severe Asthma Research Program
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 25
- Enrollment target
NCT02103348: Completed study, sponsored by University of California, San Francisco.
NCT02103348 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02103348 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
This study is designed to characterize subjects in terms of their sputum phenotype. The purpose of this study is to learn more about the impact of having abnormally elastic sputum on asthma severity by comparing subjects with severe as well as mild/moderate asthma to healthy controls. The characterization will include medical history, pulmonary function testing, imaging of the lungs and biospecimen collection.
Primary Outcome
Lung function as a measure of asthma severity.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2015-09 |
| Est. Completion | 2019-02-26 |
What the finished NCT02103348 record still lists
NCT02103348 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02103348 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02103348 about?
NCT02103348 is a clinical study titled "Characterizing Asthma Sputum Elasticity in the UCSF Severe Asthma Research Program". This study is designed to characterize subjects in terms of their sputum phenotype. The purpose of this study is to learn more about the impact of having abnormally elastic sputum on asthma severity by comparing subjects with severe as well as mild/moderate asthma to healthy controls. The characteri...
What is the current status of trial NCT02103348?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2015-09. Estimated completion is 2019-02-26.
Who is sponsoring clinical trial NCT02103348?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia